{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:28:18Z","timestamp":1784302098541,"version":"3.55.0"},"reference-count":22,"publisher":"American Association for Cancer Research (AACR)","issue":"4","license":[{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"MOST | National Key Research and Development Program of China","award":["2022YFC2505004"],"award-info":[{"award-number":["2022YFC2505004"]}]},{"name":"MOST | National Key Research and Development Program of China","award":["2022YFC2505000"],"award-info":[{"award-number":["2022YFC2505000"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81871889"],"award-info":[{"award-number":["81871889"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82072586"],"award-info":[{"award-number":["82072586"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Beijing Municipality","award":["7212084"],"award-info":[{"award-number":["7212084"]}]},{"name":"MOST | National Key Research and Development Program of China","award":["2019YFC1315700"],"award-info":[{"award-number":["2019YFC1315700"]}]},{"name":"Natural Science Foundation of Beijing Municipality","award":["7222144"],"award-info":[{"award-number":["7222144"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82102886"],"award-info":[{"award-number":["82102886"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4,4]]},"abstract":"<jats:p>Next-generation sequencing (NGS) has failed to detect mesenchymal epithelial transition factor gene (MET) polysomy in previous studies. We included three non\u2013small cell lung cancer (NSCLC) cohorts in this retrospective study to establish new criteria for detecting MET polysomy and to explore the clinical relevance of MET polysomy. Cohort 1 included 53 patients whose tissues were available for both FISH and NGS assays. Paired plasma and tissue samples were obtained from 261 patients with NSCLC as cohort 2. Cohort 3 included 46 patients with metastatic NSCLC, who presented with MET copy-number gain assessed by NGS. ROC analysis demonstrated that a cut-off point of 2.3 copies achieved the maximum Youden index in discriminating polysomy from normal copy number. Compared with the FISH test for MET polysomy, the sensitivity, specificity, and agreement of NGS were 90%, 90%, and 96.2%, respectively. Following optimization using maximum somatic allele frequency, the sensitivity and specificity of NGS for defining polysomy using plasma samples according to different circulating tumor DNA mutation frequencies were 42% and 63%. The concordance rate between tissue and plasma samples for detecting polysomy was 85%. Regarding the response to MET inhibitor, the median progression-free survival (PFS) of the MET amplification group was significantly higher than that of the polysomy group. The median PFS was similar between the polysomy and normal groups. Our results indicated that NGS may serve as an alternative method for detecting MET polysomy in NSCLC tissues. Moreover, patients with MET polysomy may not benefit from MET inhibitors.<\/jats:p>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>In this study, we established a methodology to differentiate polysomy from normal copy numbers and amplification using NGS. Moreover, this study suggests that it is critical to discriminate MET polysomy from amplification, for the former may dilute the clinical benefit of MET inhibitors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-22-0438","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T10:12:15Z","timestamp":1678097535000},"page":"532-539","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Detection of\n                    <i>MET<\/i>\n                    Polysomy by Next-generation Sequencing and Its Clinical Relevance for\n                    <i>MET<\/i>\n                    Inhibitors"],"prefix":"10.1158","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9529-7932","authenticated-orcid":true,"given":"Boyang","family":"Sun","sequence":"first","affiliation":[{"name":"1CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3908-848X","authenticated-orcid":true,"given":"Tian","family":"Qiu","sequence":"additional","affiliation":[{"name":"2Department of Pathology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3920-9114","authenticated-orcid":true,"given":"Xiaoling","family":"Zeng","sequence":"additional","affiliation":[{"name":"3Geneplus-Beijing Institute, Beijing, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3300-1707","authenticated-orcid":true,"given":"Jianchun","family":"Duan","sequence":"additional","affiliation":[{"name":"1CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1979-3760","authenticated-orcid":true,"given":"Hua","family":"Bai","sequence":"additional","affiliation":[{"name":"1CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4565-6364","authenticated-orcid":true,"given":"Jiachen","family":"Xu","sequence":"additional","affiliation":[{"name":"1CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China."},{"name":"4Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital\/Guangdong Provincial Academy of Medical Sciences, Guangdong, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2767-2985","authenticated-orcid":true,"given":"Jin","family":"Li","sequence":"additional","affiliation":[{"name":"3Geneplus-Beijing Institute, Beijing, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7361-325X","authenticated-orcid":true,"given":"Junling","family":"Li","sequence":"additional","affiliation":[{"name":"1CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1285-5562","authenticated-orcid":true,"given":"Xuezhi","family":"Hao","sequence":"additional","affiliation":[{"name":"1CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8377-3492","authenticated-orcid":true,"given":"Yutao","family":"Liu","sequence":"additional","affiliation":[{"name":"1CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7003-3356","authenticated-orcid":true,"given":"Lin","family":"Lin","sequence":"additional","affiliation":[{"name":"1CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5011-9884","authenticated-orcid":true,"given":"Hongyu","family":"Wang","sequence":"additional","affiliation":[{"name":"1CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7364-5593","authenticated-orcid":true,"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[{"name":"1CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0464-3754","authenticated-orcid":true,"given":"Jia","family":"Zhong","sequence":"additional","affiliation":[{"name":"1CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5602-0487","authenticated-orcid":true,"given":"Jie","family":"Wang","sequence":"additional","affiliation":[{"name":"1CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2692-4052","authenticated-orcid":true,"given":"Jianming","family":"Ying","sequence":"additional","affiliation":[{"name":"2Department of Pathology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7722-4956","authenticated-orcid":true,"given":"Zhijie","family":"Wang","sequence":"additional","affiliation":[{"name":"1CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2023,4,4]]},"reference":[{"key":"2023040502255740400_","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1200\/JCO.2015.63.4600","article-title":"MET exon 14 mutations in non-small-cell lung cancer are associated with advanced age and stage-dependent MET genomic amplification and c-Met overexpression","volume":"34","author":"Awad","year":"2016","journal-title":"J Clin Oncol"},{"key":"2023040502255740400_","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1141478","article-title":"MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling","volume":"316","author":"Engelman","year":"2007","journal-title":"Science"},{"key":"2023040502255740400_","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13045-021-01121-2","article-title":"Targeted therapy in advanced non-small cell lung cancer: current advances and future trends","volume":"14","author":"Majeed","year":"2021","journal-title":"J Hematol Oncol"},{"key":"2023040502255740400_","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/1878-0261.12861","article-title":"Multiplex RNA-based detection of clinically relevant MET alterations in advanced non-small cell lung cancer","volume":"15","author":"Aguado","year":"2021","journal-title":"Mol Oncol"},{"key":"2023040502255740400_","first-page":"197","article-title":"High MET copy number and MET overexpression: poor outcome in non-small cell lung cancer patients","volume":"27","author":"Park","year":"2012","journal-title":"Histol Histopathol"},{"key":"2023040502255740400_","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1158\/1078-0432.CCR-12-2246","article-title":"Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers","volume":"19","author":"Yu","year":"2013","journal-title":"Clin Cancer Res"},{"key":"2023040502255740400_","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1200\/JCO.19.00033","article-title":"MET copy number as a secondary driver of epidermal growth factor receptor tyrosine kinase inhibitor resistance in EGFR-mutant non-small-cell lung cancer","volume":"37","author":"Camidge","year":"2019","journal-title":"J Clin Oncol"},{"key":"2023040502255740400_","doi-asserted-by":"crossref","first-page":"e0146784","DOI":"10.1371\/journal.pone.0146784","article-title":"Detection of MET gene copy number in cancer samples using the droplet digital PCR method","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"2023040502255740400_","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.jtho.2019.06.009","article-title":"MET IHC is a poor screen for MET amplification or MET exon 14 mutations in lung adenocarcinomas: data from a tri-institutional cohort of the lung cancer mutation consortium","volume":"14","author":"Guo","year":"2019","journal-title":"J Thorac Oncol"},{"key":"2023040502255740400_","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.lungcan.2020.01.005","article-title":"Elucidation of the relationships of MET protein expression and gene copy number status with PD-L1 expression and the immune microenvironment in non-small cell lung cancer","volume":"141","author":"Yoshimura","year":"2020","journal-title":"Lung Cancer"},{"key":"2023040502255740400_","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jtho.2016.10.014","article-title":"Targeting MET in lung cancer: will expectations finally be MET?","volume":"12","author":"Drilon","year":"2017","journal-title":"J Thorac Oncol"},{"key":"2023040502255740400_","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1200\/JCO.18.00177","article-title":"Clonal MET amplification as a determinant of tyrosine kinase inhibitor resistance in epidermal growth factor receptor-mutant non-small-cell lung cancer","volume":"37","author":"Lai","year":"2019","journal-title":"J Clin Oncol"},{"key":"2023040502255740400_","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40164-021-00245-y","article-title":"MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors","volume":"10","author":"Peng","year":"2021","journal-title":"Exp Hematol Oncol"},{"key":"2023040502255740400_","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/annonc\/mdn635","article-title":"MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients","volume":"20","author":"Cappuzzo","year":"2009","journal-title":"Ann Oncol"},{"key":"2023040502255740400_","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2021-CT127","article-title":"Abstract CT127: Tumor response and MET-detection methods exploratory biomarker analysis of Part B of the Ph 1b TATTON study","author":"Hartmaier","year":"2021"},{"key":"2023040502255740400_","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/JTO.0b013e318168d9d4","article-title":"MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naive cohort","volume":"3","author":"Beau-Faller","year":"2008","journal-title":"J Thorac Oncol"},{"key":"2023040502255740400_","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1200\/JCO.2008.19.1635","article-title":"Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients","volume":"27","author":"Cappuzzo","year":"2009","journal-title":"J Clin Oncol"},{"key":"2023040502255740400_","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.annonc.2020.01.013","article-title":"TATTON: a multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer","volume":"31","author":"Oxnard","year":"2020","journal-title":"Ann Oncol"},{"key":"2023040502255740400_","doi-asserted-by":"crossref","first-page":"eaan2415","DOI":"10.1126\/scitranslmed.aan2415","article-title":"Direct detection of early-stage cancers using circulating tumor DNA","volume":"9","author":"Phallen","year":"2017","journal-title":"Sci Transl Med"},{"key":"2023040502255740400_","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1158\/2159-8290.CD-17-1086","article-title":"Predicting relapse with circulating tumor DNA analysis in lung cancer","volume":"7","author":"Comino-Mendez","year":"2017","journal-title":"Cancer Discov"},{"key":"2023040502255740400_","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.jtho.2021.06.017","article-title":"Liquid biopsy for advanced NSCLC: a consensus statement from the international association for the study of lung cancer","volume":"16","author":"Rolfo","year":"2021","journal-title":"J Thorac Oncol"},{"key":"2023040502255740400_","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jtho.2021.02.010","article-title":"Crizotinib in patients with MET-amplified NSCLC","volume":"16","author":"Camidge","year":"2021","journal-title":"J Thorac Oncol"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-22-0438\/3280837\/crc-22-0438.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/3\/4\/532\/3319222\/crc-22-0438.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/3\/4\/532\/3319222\/crc-22-0438.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T05:51:30Z","timestamp":1702014690000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/3\/4\/532\/725045\/Detection-of-MET-Polysomy-by-Next-generation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4,4]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-22-0438","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.22551555","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22551567","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6551227.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22551549","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546684","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22551567.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546690.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546678","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546690","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22551564","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22551552","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22551561.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22551555.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22551558","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22551549.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6551227.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546687.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546693.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22551564.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546687","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546675","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546678.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6551227","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546684.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546675.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546681.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22551552.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22551558.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546681","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22551561","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546693","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,4]]}}}